Randomized Trial of Adjuvant Tamoxifen in Node Negative Postmenopausal Breast Cancer

References

• Fisher B, Costantino J, Redmond C, et al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor positive tumors. N Engl J Med 1989; 320: 479–84
   PubMed Web of Science ®Google Scholar
• Rutqvist L E, Cedermark B, Glas U, et al. The Stockholm trial on adjuvant tamoxifen in early breast cancer. Correlation between estrogen receptor level and treatment effect. Breast Cancer Res Treat 1987; 10: 255–66
   PubMed Web of Science ®Google Scholar
• Rutqvist L E, Cedermark B, Glas U, et al. Radiotherapy, chemotherapy, and tamoxifen as adjuncts to surgery in early breast cancer: a summary of three randomized trials. Int J Radiat Oncol Biol Phys 1989; 16: 629–39
   PubMed Web of Science ®Google Scholar
• Mouridsen H, Palshof T. Tamoxifen in advanced breast cancer. Cancer Treat Rev 1978; 5: 131–41
   PubMed Web of Science ®Google Scholar
• Rutqvist L E, Cedermark B, Glas U, et al. Randomized trial of adjuvant tamoxifen combined with postoperative radiation therapy or adjuvant chemotherapy in postmenopausal breast cancer. Cancer 1990; 66: 89–96
   PubMed Web of Science ®Google Scholar
• Wrange Ö, Nordenskjöld B, Gustafsson J-Å. Cytosol estradiol receptor in human mammary carcinoma. An assay based on isoelectric focusing in polyacrylamide gel. Anal Biochem 1978; 85: 416–21
   Web of Science ®Google Scholar
• Wrange Ö, NordenskjöldSilfversw B., Ärd C, Granberg P-O, Gustafsson J-Å. Isoelectric focusing of estradiol receptor protein from human mammary carcinoma. A comparison to sucrose gradient analysis. Eur J Cancer 1976; 12: 695–700
   PubMed Web of Science ®Google Scholar
• Burton K A. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of DNA. Biochem J 1956; 62: 315–22
   PubMed Web of Science ®Google Scholar
• Ederer Cutler S.F. Maximum utilization of the life table method in analyzing survival. J Chron Dis 1958; 8: 699–710
   PubMedGoogle Scholar
• Fornander T, Rutqvist L, Cedermark E. B, et al. Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet 1989; 1: 177–20
   Web of Science ®Google Scholar
• Peto R., Pike M C, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I: Introduction and design. Br J Cancer 1976; 34: 585–612
   PubMed Web of Science ®Google Scholar
• Peto R, Pike M C, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II: Analysis and examples. Br J Cancer 1977; 35: 1–39
   PubMed Web of Science ®Google Scholar
• Haybittle J L. The reporting of non-significant results in clinical trials. Clinical trials in ‘early’ breast cancer (Lecture notes in medical informatics, vol 4), H R Scheurlen, G Weckesser, I Armbruster. Springer-Verlag, Berlin-Heidelberg 1979; 28–39
   Google Scholar
• Nolvadex Adjuvant Trial Organisation. Controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer. Analysis at six years by the Nolvadex Adjuvant Trial Organisation. Lancet 1985; 1: 836–40
   PubMed Web of Science ®Google Scholar
• Breast Cancer Trials Committee, Scottish Cancer Trials Office. Adjuvant tamoxifen in the management of operable breast cancer: the Scottish trial. Lancet 1987; 2: 171–5
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Treatment of early breast cancer: worldwide evidence in 1985–1990. A systematic overview of all available randomized trials in early breast cancer of adjuvant endocrine and cytotoxic therapy. Treatment of early breast cancer. Oxford University Press, Oxford 1990; Vol. I
   Google Scholar
• Jordan V C. Use of the DMBA-induced rat mammary carcinoma system for the evaluation of tamoxifen treatment as a potential adjuvant treatment. Rev Endocrinol Relat Cancer 1978, Suppl Oct: 49–55
   Google Scholar
• Uppsala-Örebro Breast Cancer Study Group. Sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. JNCI 1990; 82: 277–82
   PubMedGoogle Scholar